Lavialle C, Modjtahedi N, Cassingena R, Brison O
ER 278 CNRS, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Oncogene. 1988 Sep;3(3):335-9.
The c-myc gene is amplified in the SW 613-S cell line which was established from a human breast carcinoma. This line is heterogeneous: it contains cells with a high level of amplification and carrying the extra copies of the c-myc gene in double minute chromosomes (DMs) and cells with few c-myc genes integrated into chromosomes. Clones with different levels of amplification and different cytological localization of the c-myc copies were isolated from the SW 613-S cell population. Those with a high level of amplification and expression of the c-myc gene were highly tumorigenic in nude mice whereas those with a low level were not. Introduction of c-myc gene copies by transfection into the cells of several non-tumorigenic clones restored the tumorigenic phenotype. Our results indicate that a high level of amplification of the c-myc gene is a requirement for the tumorigenicity of SW 613-S cells in animals.
c-myc基因在源自人乳腺癌的SW 613-S细胞系中发生扩增。该细胞系具有异质性:它包含c-myc基因高水平扩增并在双微体染色体(DMs)中携带额外拷贝的细胞,以及c-myc基因少量整合到染色体中的细胞。从SW 613-S细胞群体中分离出具有不同扩增水平和c-myc拷贝不同细胞学定位的克隆。c-myc基因高水平扩增和表达的克隆在裸鼠中具有高度致瘤性,而低水平的则没有。通过转染将c-myc基因拷贝导入几个非致瘤性克隆的细胞中可恢复致瘤表型。我们的结果表明,c-myc基因的高水平扩增是SW 613-S细胞在动物中致瘤性的必要条件。